These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8866827)

  • 21. LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats.
    Pinheiro-Júnior EL; Boldrini-França J; de Campos Araújo LMP; Santos-Filho NA; Bendhack LM; Cilli EM; Arantes EC
    Peptides; 2018 Apr; 102():1-7. PubMed ID: 29410030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
    Kozlovski VI; Lomnicka M; Jakubowski A; Chlopicki S
    Pharmacol Rep; 2007; 59(4):421-7. PubMed ID: 17901571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function studies on the bradykinin potentiating peptide from Chinese snake venom (Agkistrodon halys Pallas).
    Chi CW; Wang SZ; Xu LG; Wang MY; Lo SS; Huang WD
    Peptides; 1985; 6 Suppl 3():339-42. PubMed ID: 3008123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.
    Dendorfer A; Reibetamann S; Wolfrum S; Raasch W; Dominiak P
    Hypertension; 2001 Jul; 38(1):142-6. PubMed ID: 11463775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
    Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
    Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
    J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kallikrein, kininase and related peptides activities in central Asian snake venoms.
    Yukelson LYa ; L'vov VM; Shkinev AV; Sultanalieva N
    Agents Actions Suppl; 1992; 38 ( Pt 1)():430-40. PubMed ID: 1334625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational and biological properties of Bauhinia bauhinioides kallikrein inhibitor fragments with bradykinin-like activities.
    Alves FL; Oliva ML; Miranda A
    J Pept Sci; 2015 Jun; 21(6):495-500. PubMed ID: 25902925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
    Field JL; Butt SK; Morton IK; Hall JM
    Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of RMP-7, a novel bradykinin agonist in smooth muscle.
    Shimuta SI; Barbosa AM; Borges AC; Paiva TB
    Immunopharmacology; 1999 Dec; 45(1-3):63-7. PubMed ID: 10614991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.
    Gera L; Roy C; Bawolak MT; Bouthillier J; Adam A; Marceau F
    Pharmacol Res; 2011 Nov; 64(5):528-34. PubMed ID: 21864683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
    Stanziola L; Greene LJ; Santos RA
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom.
    Ferreira LA; Möllring T; Lebrun FL; Raida M; Znottka R; Habermehl GG
    Toxicon; 1995 Oct; 33(10):1313-9. PubMed ID: 8599182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.
    Bakhle YS
    Br J Pharmacol; 1977 Jan; 59(1):123-8. PubMed ID: 189870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.